OSCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Oscar Health Inc (OSCR) does not present a compelling buy opportunity at this time for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company shows revenue growth and market penetration, its widening losses, bearish technical indicators, and lack of strong trading signals suggest it is better to hold off on investing until clearer signs of profitability and upward momentum emerge.
The technical indicators for OSCR are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 52.497, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 13.386, with resistance at 14.589 and support at 12.183. This suggests limited upward momentum in the near term.
Revenue grew 17% YoY in Q4 2025, reaching $2.81 billion.
Total membership surpassed 2 million, indicating strong market penetration.
Analysts like Raymond James and Barclays see potential for margin recovery and attractive valuation.
Net loss widened to $353 million in Q4 2025, reflecting ongoing profitability challenges.
Expiration of enhanced premium tax credits is expected to elevate churn rates in
Technical indicators and options data suggest limited near-term upside.
In Q4 2025, Oscar Health reported revenue of $2.81 billion, a 17.3% YoY increase. However, net income was -$353 million, reflecting a 129.64% YoY increase in losses. EPS was -1.24, showing no improvement. The company projects 2026 revenue between $18.7 billion and $19 billion, but profitability remains a concern.
Analysts are mixed but leaning positive. Raymond James upgraded the stock to Outperform with an $18 price target, citing margin recovery. Barclays also upgraded to Equal Weight with an $18 target. However, UBS lowered its price target to $15, maintaining a Neutral rating, and Jefferies has an Underperform rating with a $12 target. The stock is seen as attractively priced but faces significant challenges.
